definiens: as defined in the,1CDiAgreement, the licenses granted to [COMPANY] u;'der the J ~ SMA - Agre;ment and J = D3'~ Ah,'Teement, respectively, are non - exclusive licenses, and that the sublic ~ nse ~ " --, S'1'anted by Mierol11ct to [COMPANY] under Section 7.1.2 of each of the ' PSMA ' Agreement and : tD3J Agreement is, _ a nOl~:exclusivc sublieens~ under the--- ' license granted to [COMPANY] under the'[SM ~ Agreement and ~ D ~ Agreement, respectively ; and C. Pursuant Section 2,1 of each of the ~ RSMAJAgreeme ~ t and ', fD3iAgree : g!ent, _, the licenses granted to [COMPANY] under the tRSMA ; Agreement and - .. CDL ' Agreement, respectively, only extend to Licensed Products, \",hich are products, substances or fommlations arising from a Target Program ( as defined in thdPSMA, Agreemcnt and'CD3-'Agreement, respectively ) ; and -- ---d, Pursuant to Section 2.3 of each of the ; -PSMAAgrccl11cnt and'_i = D3, ' Agreement, Cl::ATJ has not granted to [COMPANY] ~ any rights to research, develop, manufacture, use or sell products using ! CAT Ribosome Display or Catalytic r ;, " " -- ~, Antibodies ! ( eaeh as defined in the',JSM~ ' Agreement and ' £ : D3, I Agreement, respectiveiY ) or to develop, manufacture, use or sell any pro(fuet that is a Research Product o/.&ricroarray:(each as defined in the ~ SMA : Agrccment ancl j - CDJ, Agreement respectively)~ ' and : Niicromet does not grallt to [COMPANY] any -nghts under the Agreement to research, develop, manufacture, use or sell Products using ~ AT Ribosome Displ ~ X or CataI}1ic AntibodicD(eaeh as defined in the : PSMA]Agreement and, ~D:£JAgreement, respectively ) or to, --;develop, ~anufacture, use or sell a~ Pro ~ llct that is a Re ~ arcJ~ Product or LMicroarra~ ( each as defined in the ' ~SMAJ Agreement and & D3J Agreement, respectively )